XML 41 R24.htm IDEA: XBRL DOCUMENT v3.7.0.1
Acquisitions and Divestitures Acquisitions and Divestitures (Tables)
3 Months Ended
Mar. 31, 2017
Discontinued Operations and Disposal Groups [Abstract]  
Assets and Liabilities Held for Sale
The following table presents information related to the major classes of assets and liabilities that were classified as held for sale in our condensed consolidated balance sheets (in millions):
 
March 31,
2017

 
December 31, 2016

 
Cash, cash equivalents and short-term investments
$
317

 
$
49

 
Trade accounts receivable, less allowances
264

 
43

 
Inventories
268

 
264

 
Prepaid expenses and other assets
105

 
114

 
Equity method investments

 
1

 
Other investments
42

 
42

 
Other assets
19

 
17

 
Property, plant and equipment — net
2,093

 
1,780

 
Bottlers' franchise rights with indefinite lives
2,501

 
1,388

 
Goodwill
744

 
390

 
Other intangible assets
98

 
51

 
Allowance for reduction of assets held for sale
(662
)
 
(1,342
)
 
Total assets
$
5,789

1 
$
2,797

3 
Accounts payable and accrued expenses
$
553

 
$
393

 
Loans and notes payable
745

 

 
Accrued income taxes
13

 
13

 
Other liabilities
7

 
1

 
Deferred income taxes
908

 
303

 
Total liabilities
$
2,226

2 
$
710

4 

1 Consists of total assets relating to North America refranchising of $4,163 million, China bottling operations of $1,609 million and other assets held for sale of $17 million, which are included in the Bottling Investments and Corporate operating segments.
2 
Consists of total liabilities relating to North America refranchising of $1,639 million, China bottling operations of $584 million and other liabilities held for sale of $3 million, which are included in the Bottling Investments and Corporate operating segments.
3 Consists of total assets relating to North America refranchising of $1,247 million, China bottling operations of $1,533 million and other assets held for sale of $17 million, which are included in the Bottling Investments and Corporate operating segments.
4 
Consists of total liabilities relating to North America refranchising of $224 million, China bottling operations of $483 million and other liabilities held for sale of $3 million, which are included in the Bottling Investments and Corporate operating segments.
We determined that the operations included in the table above did not meet the criteria to be classified as discontinued operations under the applicable guidance.